trial · primary record
Bevacizumab
Respiratory Tract Diseases
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 21 |
| Primary completion | 2029-01-01 |
| Primary endpoint | To determine the percentage of participants with an increase in their surgery-free interval during treatment with systemic bevacizumab. |
| Registry ID | NCT05797246 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:34.854Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05797246
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Bevacizumab · compound